Week On Wall Street
  • Home
  • Personal Finance
  • Investing
    • Investing
    • Advisors
    • Investor Tips
  • Earnings
  • Taxes
  • Real Estate
  • Retirement
  • Business
    • Business
    • Small Business
  • Finance
    • Finance
    • Wealth
  • Privacy Policy
    • DMCA / Copyrights Disclaimer
    • Terms and Conditions
Skip to content
  • Personal Finance
  • Investing
    • Investing
    • Advisors
    • Investor Tips
  • Earnings
  • Taxes
  • Real Estate
  • Retirement
  • Business
    • Business
    • Small Business
  • Finance
    • Finance
    • Wealth
  • Privacy Policy
    • DMCA / Copyrights Disclaimer
    • Terms and Conditions
Investor Tips
A value needle in a haystack of frothy SPAC valuations

Articles You May Like

Is Ross Stores (ROST) a ‘Buy’ Ahead of Its Upcoming Earnings Announcement?
5 Must-See Earnings Charts This Week
Top Stock Picks for Week of November 10, 2025
Reddit (RDDT) and DraftKings (DKNG): 11/13/25 Bull & Bear

Newsletter

Recent Articles

  • 5 Must-See Earnings Charts This Week
  • Is Ross Stores (ROST) a ‘Buy’ Ahead of Its Upcoming Earnings Announcement?
  • Top Stock Picks for Week of November 10, 2025
  • Reddit (RDDT) and DraftKings (DKNG): 11/13/25 Bull & Bear
  • 3 Hidden Gem AI Stocks to Buy Now
  • Zacks Strategist Shaun Pruitt Talks Stocks to Watch for the First $Trillion Holiday Shopping Season
  • CoreWeave Drops 13% after Earnings Beat
  • nVent Electric (NVT) and MGM Resorts (MGM): 11/6/25 Bull & Bear
  • 3 Top Ranked Stocks that are the Best of the Best
  • Zacks Strategist Shaun Pruitt Discusses the Hype for Shopify Stock

Earnings

  • Super Micro Computer shares surge 19% after company files delayed financials by deadline
  • Here’s why Home Depot remains a buy after retailer clears lowered earnings bar
  • Lucid CEO steps down; EV maker plans to more than double production in 2025
  • Workday beats estimates for revenue and profit, stock jumps
  • Chegg sues Google for hurting traffic with AI as it considers strategic alternatives

Business

  • Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
  • Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
  • Home Depot earnings beat Wall Street estimates, as retailer breaks comparable sales losing streak
  • How digitally native companies like Rothy’s are growing profitably in a new era for retail
  • Starbucks to lay off 1,100 corporate workers as sales sag

Useful Links

  • DMCA / Copyrights Disclaimer
  • Terms and Conditions
  • Whitelist Us
  • Privacy Policy

Copyright © 2025 by Week On Wall Street. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified.

Powered by WordPress using DisruptPress Theme.